March 2009. Volume 5. Number 1

Nebulized hypertonic saline solution can reduce the length of hospital stay in infants with acute bronchiolitis

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Zhang L, Mendoza-Sasi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews 2008, Isue 4. Art. No.: CD006458. DOI: 10.1002/14651858.CD006458.pub2
Reviewers: Balaguer Santamaría A1, Buñuel Álvarez JC2, González de Dios J3.
1H General Catalunya. Sant Cugat del Vallés. Barcelona. España.
2Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
3Departamento de Pediatría. Hospital General Universitario de Alicante. España.
Correspondence: Albert Balaguer Santamaría. Email: balaguer.albert@gmail.com
Reception date: 09/01/2009
Acceptance date: 12/01/2009
Publication date: 14/01/2009

Abstract

Authors' conclusions: current data suggest that 3% nebulized hypertonic saline solution can reduce hospital stay and improve the clinical severity score of infants with bronchiolitis.

Reviewers' comantary: this is a rigorous systematic review of four well-designed studies in which there is no notable heterogeneity, but it included few patients. The results show the effectiveness of nebulized hypertonic compared to normal saline solution to reduce the length of hospitalization (0.9 days) and respiratory clinical score.

How to cite this article

Balaguer Santamaría A, Buñuel Álvarez JC, González de Dios J. El suero salino hipertónico nebulizado puede disminuir la duración del ingreso hospitalario en lactantes con bronquiolitis aguda. Evid Pediatr. 2009;1:5.

AVC | Critically appraised articles

Zhang L, Mendoza-Sasi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews 2008, Isue 4. Art. No.: CD006458. DOI: 10.1002/14651858.CD006458.pub2
Reviewers: Balaguer Santamaría A1, Buñuel Álvarez JC2, González de Dios J3.
1H General Catalunya. Sant Cugat del Vallés. Barcelona. España.
2Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
3Departamento de Pediatría. Hospital General Universitario de Alicante. España.
Correspondence: Albert Balaguer Santamaría. Email: balaguer.albert@gmail.com
Reception date: 09/01/2009
Acceptance date: 12/01/2009
Publication date: 14/01/2009

How to cite this article

Balaguer Santamaría A, Buñuel Álvarez JC, González de Dios J. El suero salino hipertónico nebulizado puede disminuir la duración del ingreso hospitalario en lactantes con bronquiolitis aguda. Evid Pediatr. 2009;1:5.

References

  1. Wark PA, McDonald V, Jones AP. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001506.
  2. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, Mandelberg A. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122:2015-20.
  3. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, Priel IE. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123:481-7.
  4. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J. 2006;8:169–73.
  5. Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, Gander S. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151:266-70.
  6. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992 Jan;145:106-9.
14/01/2009

Linked Comment